Improving myocardial protection. The key variables, which effect troponin release after CABG.

David Sladden, Kevin Schembri, Liberato Camilleri, Robert Xuereb, Joseph Galea

Abstract


Background

Myocardial cell ischaemic injury during cardiopulmonary bypass and aortic crossclamp remains a key limiting factor to patient outcomes in coronary artery bypass grafting. Troponin I has been shown to be an effective indicator of myocardial ischaemic injury and achieves peak levels early post-operatively.

Methods

All consenting CABG patients from one centre, during a one year period, were recruited. All surgeries were performed using identical techniques besides the cardioplegia volume and number of doses. Troponin I levels were checked regularly post-operatively until a peak troponin I level was ascertained. All the patient demographics, crossclamp times, bypass times and cardioplegia dosing were analysed using multiple combinations of statistical tools.

Results

172 patients were included in the study and cardiopulmonary bypass (CPB) time was found to be significant as a single variable (p=0.033). The combination of CBP time and ischaemia time (p=0.002) and the combination of CPB time and multidose cardioplegia (p=0.009), were both found to significantly effect peak troponin I levels. Another analysis was performed on the volume of cardioplegia used. While this was not significant as an individual variable it did become significant when combined with ischaemia time at a threshold total cardioplegia volume of 750mls (p=0.026).

Conclusions

The conclusion therefore is that using over 750mls of cardioplegia in multiple doses will safely protect against an ischaemia time of up to 62min. However there is no protection against the CPB time, which proved to have the most impact on myocardial cell damage in our practice. 


Keywords


Cardioplegia, Myocardial protection, ischaemic cell injury, cardiopulmonary bypass, coronary artery bypass graft

Full Text:

PDF

References


Kouchoukos NT, Blackstone EH, Hanley FL, Kirklin JK. Kirklin/Barratt-Boyes Cardiac Surgery, 4th Ed. Elsevier Saunders, Philadelphia 2013.

Menasche P, Kural S, Fauchet M, Commin P, Bercot M, Touchot B. Retrograde coronary sinus perfusion: a safe alternative for ensuring cardioplegic delivery in aortic valve surgery. Ann Thoracic Surg 1982;34:647.

Conti VR, Bertranou EG, Blackstone EH, Kirklin JW, Digerness SB. Cold cardioplegia versus hypothermia for myocardial protection. Randomised clinical study. J Thoracic Cardiovasc Surg 1978;76:577.

Oldham HN Jr. Intraoperative detection of myocardial damage during coronary artery surgery by plasma creatine phosphokinase isoenzyme analysis. Surgery 1973; 74:917. PMID: 4749633.

Roe CR, Wagner GS. Relation of creatine kinase isoenzyme MB to post-operative electrocardiographic diagnosis in patients undergoing coronary artery bypass surgery. Clin Chem 1979; 25:93

Paparella D, Guida P, Caparrotti S, Fanelli V, Martinelli G, Mazzei V, Zaccaria S, Bisceglia L, Scrascia G. Myocardial damage influences short- and mid-term survival after valve surgery: A prospective multicenter study. J Thorac Cardiovasc Surg. 2013 Nov 27. pii: S0022-5223(13)01291-9.

Noora J, Ricci C, Hastings D, Hill S, Cybulsky I. Determination of troponin I release after CABG surgery. J Card Surg. 2005 Mar-Apr;20(2):129-35. DOI: 10.1111/j.0886-0440.2005.200387.

Mastro F, Guida P, Scrascia G, Rotunno C, Amorese L, Carrozzo A, Capone G, Paparella D. Cardiac troponin I and creatine kinase-MB release after different cardiac surgeries. J Cardiovasc Med. 2014 Jul 11.

Christopher B. Overgaard, Vladimír Dzavík. Inotropes and Vasopressors: Review of Physiology and Clinical Use in Cardiovascular Disease. Circulation. 2008;118:1047-1056. DOI: 10.1161/CIRCULATIONAHA.107.728840.

Asli Tanindi, Mustafa Cemri. Troponin elevation in conditions other than

acute coronary syndromes. Vascular Health and Risk Management 2011:7 597–603. doi: 10.2147/VHRM.S24509.

Archie JP Jr. Determinates of regional intramyocardial pressure. J Surg Res 1973;14:338.

Bladergroen MR, Takei H, Christopher TD, Cummings RG, Blanchard SM, Lowe GE. Accelerated transmurasl gradients of energy compound metabolism resulting from left ventricular hypertrophy. J thorac Cardiovasc Surg 1990;100:506.

Steed D, Follette D, Foglia R, Buckberg G. Unavoidable subendocardial underperfusion during bypass, especially in infants. Circulation 1977;56:III 248

Blackstone EH, Kirklin JW, Steward RW, Chenoweth DE. Damaging effects of cardiopulmonary bypass. In Wu KK, Rossi EC, eds. Prostaglandins in clinical medicine. Chicago: Year Book Medical Publishers, 1982;355.

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4




DOI: https://doi.org/10.17987/icfj.v9i0.349

Comments on this article

View all comments


Copyright (c) 2017 David Sladden, Kevin Schembri, Liberato Camilleri, Robert Xuereb, Joseph Galea

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.